Inhibiting the interaction of PD1 and PDL1 in a variety of clinically relevant animal models of sepsis has been shown to improve survival rates and highlights the crucial involvement of this pathway with poor disease outcome [41–43]. The gene discussed is CD274; the disease is Sepsis.